Literature DB >> 22627859

Emerging concepts in haematopoietic cell transplantation.

Hao Wei Li1, Megan Sykes.   

Abstract

Haematopoietic cell transplantation (HCT) is the most widely used form of cellular therapy. It is the only known cure for some haematological malignancies and has recently been used in additional clinical settings, such as allograft tolerance induction and treatment of autoimmune diseases. Recent advances have enabled HCT in a wider range of patients with improved outcomes. This Review summarizes the latest developments in this therapy, focusing on issues that will affect future advancement.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22627859      PMCID： PMC4006975          DOI： 10.1038/nri3226

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  112 in total

Review 1.  Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance.

Authors:  Megan Sykes; Ichiro Shimizu; Toshiyasu Kawahara
Journal:  Transplantation       Date:  2005-02-15       Impact factor: 4.939

2.  Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

Authors:  Scott R Solomon; Stephan Mielke; Bipin N Savani; Aldemar Montero; Laura Wisch; Richard Childs; Nancy Hensel; John Schindler; Victor Ghetie; Susan F Leitman; Thao Mai; Charles S Carter; Roger Kurlander; Elizabeth J Read; Ellen S Vitetta; A John Barrett
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

3.  Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.

Authors:  Markus Y Mapara; Corinna Leng; Yong-Mi Kim; Roderick Bronson; Anna Lokshin; Andrew Luster; Megan Sykes
Journal:  Biol Blood Marrow Transplant       Date:  2006-06       Impact factor: 5.742

4.  Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-gamma-producing CD8+ T cells.

Authors:  Marie-Therese Rubio; Toshiki I Saito; Kristin Kattleman; Guiling Zhao; Jennifer Buchli; Megan Sykes
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

5.  Protective conditioning for acute graft-versus-host disease.

Authors:  Robert Lowsky; Tsuyoshi Takahashi; Yin Ping Liu; Sussan Dejbakhsh-Jones; F Carl Grumet; Judith A Shizuru; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Richard T Hoppe; Daniel A Bloch; Karl G Blume; Robert S Negrin; Samuel Strober
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

6.  Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.

Authors:  Fabrizio Carnevale-Schianca; Alessandro Cignetti; Antonio Capaldi; Katiuscia Vitaggio; Antonella Vallario; Alberto Ricchiardi; Elisa Sperti; Renato Ferraris; Marco Gatti; Giovanni Grignani; Delia Rota-Scalabrini; Massimo Geuna; Marco Fizzotti; Dario Sangiolo; Antonino Sottile; Giovanni De Rosa; Anna Rosa Bucci; Giorgio Lambertenghi-Deliliers; Edoardo Benedetti; Richard Nash; Massimo Aglietta
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

7.  Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network.

Authors:  Ismé de Kleer; Bas Vastert; Mark Klein; Gijs Teklenburg; Ger Arkesteijn; Gisella Puga Yung; Salvo Albani; Wietse Kuis; Nico Wulffraat; Berent Prakken
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

8.  Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.

Authors:  Georg F Beilhack; Rosa R Landa; Marilyn A Masek; Judith A Shizuru
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

9.  Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

Authors:  Luca Gattinoni; Steven E Finkelstein; Christopher A Klebanoff; Paul A Antony; Douglas C Palmer; Paul J Spiess; Leroy N Hwang; Zhiya Yu; Claudia Wrzesinski; David M Heimann; Charles D Surh; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

10.  Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

Authors:  Paolo A Muraro; Daniel C Douek; Amy Packer; Katherine Chung; Francisco J Guenaga; Riccardo Cassiani-Ingoni; Catherine Campbell; Sarfraz Memon; James W Nagle; Frances T Hakim; Ronald E Gress; Henry F McFarland; Richard K Burt; Roland Martin
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307
View more
  52 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 2.  Induction of tolerance through mixed chimerism.

Authors:  David H Sachs; Tatsuo Kawai; Megan Sykes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

3.  "Anatomy of an Illness": control from a caregiver's perspective.

Authors:  Mark L Laudenslager
Journal:  Brain Behav Immun       Date:  2013-09-06       Impact factor: 7.217

4.  Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness.

Authors:  Edward O Kwarteng; Krista M Heinonen
Journal:  J Vis Exp       Date:  2016-08-31       Impact factor: 1.355

5.  Dendritic cell-MHC class II and Itk regulate functional development of regulatory innate memory CD4+ T cells in bone marrow transplantation.

Authors:  Qian Qi; Jianfang Hu; Weishan Huang; Fei Huang; Terri M Laufer; Avery August
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 6.  Immune recognition of irradiated cancer cells.

Authors:  Erik Wennerberg; Claire Vanpouille-Box; Sophia Bornstein; Takahiro Yamazaki; Sandra Demaria; Lorenzo Galluzzi
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

7.  CD201 and CD27 identify hematopoietic stem and progenitor cells across multiple murine strains independently of Kit and Sca-1.

Authors:  Sara E Vazquez; Matthew A Inlay; Thomas Serwold
Journal:  Exp Hematol       Date:  2015-04-16       Impact factor: 3.084

8.  Cooperation of CD4+ T cells and CD8+ T cells and release of IFN-γ are critical for antileukemia responses of recipient mice treated by microtransplantation.

Authors:  Li Wang; Fan Du; Hongxiang Wang; Conghua Xie
Journal:  Exp Ther Med       Date:  2017-11-22       Impact factor: 2.447

9.  Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; David Tollerud; Mary Jane Elliott; Larry D Bozulic; Christopher Houston; Nedjema Sustento-Reodica; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

10.  Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.

Authors:  Marco Andreani; Monica Emma Gianolini; Manuela Testi; MariaRosa Battarra; Galluccio Tiziana; Aldo Morrone; Pietro Sodani; Guido Lucarelli; Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Chimerism       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.